JAX Mouse Strain Datasheet - 007561

B6.129-Hif1a^tm3Rsjo/J

Stock No:: 007561 |; HIF1α^flox

Repository Live

Overview

Also Known As: HIF1α^flox

When these Hif1a^tm3Rsjo floxed mice are bred to mice that express Cre recombinase, resulting offspring will have exon 2 deleted in the cre-expressing tissue(s). Mice from this strain can be crossed to strains expressing Cre recombinase in various tissues and may be useful for studies of the role of HIF transcription factors in von Hippel-Landau syndrome, adult erythropoiesis, inflammation, mammary epithelium, tumor angiogenesis, and lung development as examples.

Donating Investigator

Randall Johnson, UC-San Diego

Genetic overview

Genetic Background	Generation
	N12+N2F7 (27-JUN-16)

Hif1a^tm3Rsjo

Allele Type	Gene Symbol	Gene Name
Targeted (Conditional ready (e.g. floxed), No functional change)	Hif1a	hypoxia inducible factor 1, alpha subunit

View Genetics

Research Applications

Research Tools

View All Research Applications

Base Price

Starting at:

$246.50 Domestic price for female

View Price List

Details

Detailed Description

These mice possess loxP sites on either side of exon 2 of the targeted gene. Mice that are homozygous for this allele are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. When these mutant mice are bred to mice that express Cre recombinase, resulting offspring will have exon 2 deleted in the cre-expressing tissue(s).

For example, when crossed to a strain expressing Cre recombinase in skeletal and cardiac muscle (see Stock No. 006475), this mutant mouse strain may be useful in studies of the metabolic control of muscle function.

When bred to a strain with the targeted null allele in von Hippel-Lindau syndrome homolog, Vhlh (Stock No. 004081) and a strain expressing Cre recombinase in liver (Stock No. 003574), this mutant mouse strain may be useful in the role of HIF transcription factors in von Hippel-Landau syndrome.

When crossed to a tamoxifen inducible strain with widespread Cre recombinase expression (see Stock No. 008085), this mutant mouse strain may be useful in studies of adult erythropoiesis.

When bred to a strain expressing Cre recombinase in the myeloid cell lineage (see Stock No. 004781 for example), this mutant mouse strain may be useful in studies of inflammation.

When bred to a strain expressing Cre recombinase in the mammary gland and other secretory tissues (see Stock No. 003551 for example), this mutant mouse strain may be useful in studies of mammary epithelium.

When bred to a strain expressing Cre recombinase in vascular endothelial cells (see Stock No. 008863 for example), this mutant mouse strain may be useful in studies of tumor angiogenesis.

When bred to a strain expressing Cre recombinase under the control of a tetracycline-responsive promoter element and a strain expressing a tetracycline-controlled activator protein in lung epithelial cells (see Stock No. 006234 and 006235 respectively), this mutant mouse strain may be useful in studies of lung development.

Development

Similarly oriented loxP sites were placed upstream of exon 2 and flanking the neomycin resistance cassette (located in intron 2). The construct was electroporated into (129X1/SvJ x 129S1/Sv)F1-derived R1 embryonic stem (ES) cells. Correctly targeted ES cells were transiently transfected with a cre expression plasmid for the purpose of removing the selectable marker cassette. ES cells that had successfully undergone Cre-mediated recombination and no longer retained the cassette but did retain the loxP flanked exon 2 were injected in C57BL/6 blastocysts. The donating investigator reported that the resulting chimeric male animals were backcrossed to wildtype C57BL/6J mice (see SNP note below) for 12 generations. A speed congenic protocol was used for the first 6 generations of backcrossing, after which the mice were backcrossed an additional 6 generations to C57BL/6J (see SNP note below) prior to arriving at The Jackson Laboratory. The Y chromosome may not have been fixed to the C57BL/6J genetic background.

A 32 SNP (single nucleotide polymorphism) panel analysis, with 27 markers covering all 19 chromosomes and the X chromosome, as well as 5 markers that distinguish between the C57BL/6J and C57BL/6N substrains, was performed on the rederived living colony at The Jackson Laboratory Repository. While the 27 markers throughout the genome suggested a C57BL/6 genetic background, at least 2 of 5 markers that determine C57BL/6J from C57BL/6N were found to be segregating. These data suggest the mice sent to The Jackson Laboratory Repository were on a mixed C57BL/6J ; C57BL/6N genetic background.

Control Suggestions

000664 C57BL/6J

Additional Information

Considerations for Choosing Controls

Selected References

Ryan HE; Poloni M; McNulty W; Elson D; Gassmann M; Arbeit JM; Johnson RS. 2000. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res 60(15):4010-5. PubMed: 10945599 MGI: J:78980

View All References

Genetics

Hif1a^tm3Rsjo

Allele Symbol: Hif1a^tm3Rsjo

Allele Name	targeted mutation 3, Randall S Johnson
Allele Type	Targeted (Conditional ready (e.g. floxed), No functional change)
Allele Synonym(s)	+^f; HIF-1alpha^+f; HIF-1alpha^F; HIF1a^f+; HIF1alpha^flox; Hif-1alpha 2-lox; Hif1a^2lox; Hif1a^fl; Hif1a^loxP; Hif^+f; Hif^f; I.1-^lox
Gene Symbol and Name	Hif1a, hypoxia inducible factor 1, alpha subunit
Gene Synonym(s)	AA959795; HIF-1-alpha; HIF-1A; HIF-1alpha; HIF1; HIF1-ALPHA; HIF1alpha; MOP1; PASD8; bHLHe78; expressed sequence AA959795
Strain of Origin	(129X1/SvJ x 129S1/Sv)F1-Kitl<+>
Chromosome	12
Molecular Note	A loxP site was inserted in intron 1 and a floxed neomycin resistance cassette was placed in intron 2. Exon 2 was left flanked by loxP sites after the neo cassette was excised by in vitro expression of cre recombinase.
Mutations Made By	Randall Johnson, UC-San Diego

Disease/Phenotype

Disease Terms

Research Areas By Genotype

This mouse can be used to support research in many areas including:

Research Tools
- Cre-lox System
  - loxP-flanked Sequences

Mammalian Phenotype Terms by Genotype

The following phenotype information is associated with a similar, but not exact match to this JAX^® Mice strain

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo
involves: 129S1/Sv * 129X1/SvJ

homeostasis/metabolism phenotype

abnormal gluconeogenesis
- in mice exposed to a cre-expressing adenovirus following partial hepatectomy

decreased circulating glucose level
- following partial hepatectomy, fed or fasted mice exposed to a cre-expressing adenovirus exhibit a greater decrease in circulating glucose levels compared with similarly treated wild-type mice

decreased glycogen level
- in the liver of fed, but not fasted, mice exposed to a cre-expressing adenovirus 72 hours after partial hepatectomy

cellular phenotype

decreased cell proliferation
- adenoviral cre-treated mouse embryonic fibroblasts exhibit reduced proliferation under normoxic or hypoxic conditions compared with similarly treated wild-type cells

decreased hepatocyte proliferation
- in mice exposed to a cre-expressing adenovirus following partial hepatectomy

early cellular replicative senescence
- under normoxic conditions, adenoviral cre-treated mouse embryonic fibroblasts exhibit premature replicative senescence compared with similarly treated wild-type cells

increased cellular sensitivity to gamma-irradiation
- in adenoviral cre-treated mouse embryonic fibroblasts

liver/biliary system phenotype

decreased hepatocyte proliferation
- in mice exposed to a cre-expressing adenovirus following partial hepatectomy

decreased liver regeneration
- following exposure to a cre-expressing adenovirus, recovery from partial hepatectomy is delayed compared to in similarly treated wild-type mice

The following phenotype relates to a compound genotype created using this strain

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Lyz2^tm1(cre)Ifo/Lyz2⁺
involves: 129P2/OlaHsd 129S1/Sv 129X1/SvJ

immune system phenotype

abnormal leukocyte physiology
- CD44^hi myeloid cells fail to promote repair of oxygen-induced retinopathy unlike wild-type cells

abnormal macrophage physiology
- bacteria exposed macrophages contain 7-fold more viable bacteria than similarly treated wild-type mice
- macrophages exhibit impaired glycolysis and energy generation compared with wild-type cells
- macrophages lack homotypic adhesion unlike wild-type cells

decreased inflammatory response
- TPA-treated ears exhibit reduced inflammatory infiltration and edema compared with similarly treated wild-type cells
- following disruption of barrier function with 5% SDS (chronic cutaneous inflammation), mice fail to exhibit an inflammatory response as in similarly treated wild-type mice

decreased susceptibility to induced arthritis

decreased tumor necrosis factor secretion
- in LPS-treated macrophages

impaired macrophage chemotaxis
- macrophage capacity to invade matrigel is severely defective compared with wild-type mice
- macrophage exhibit reduced directed motility in the absence of matrigel by 50% at normoxia and 75% under hypoxic conditions compared with similarly treated wild-type cells
- macrophage migration through artificial extracellular matrix is decreased 60% compared with wild-type cells

homeostasis/metabolism phenotype

increased susceptibility to injury
- CD44^hi myeloid cells fail to promote repair of oxygen-induced retinopathy unlike wild-type cells
- following oxygen-induced retinopathy, mice exhibit decreased repair of retinal damage compared with similarly treated wild-type mice

skeleton phenotype

decreased susceptibility to induced arthritis

cellular phenotype

impaired macrophage chemotaxis
- macrophage capacity to invade matrigel is severely defective compared with wild-type mice
- macrophage exhibit reduced directed motility in the absence of matrigel by 50% at normoxia and 75% under hypoxic conditions compared with similarly treated wild-type cells
- macrophage migration through artificial extracellular matrix is decreased 60% compared with wild-type cells

hematopoietic system phenotype

abnormal leukocyte physiology
- CD44^hi myeloid cells fail to promote repair of oxygen-induced retinopathy unlike wild-type cells

abnormal macrophage physiology
- bacteria exposed macrophages contain 7-fold more viable bacteria than similarly treated wild-type mice
- macrophages exhibit impaired glycolysis and energy generation compared with wild-type cells
- macrophages lack homotypic adhesion unlike wild-type cells

impaired macrophage chemotaxis
- macrophage capacity to invade matrigel is severely defective compared with wild-type mice
- macrophage exhibit reduced directed motility in the absence of matrigel by 50% at normoxia and 75% under hypoxic conditions compared with similarly treated wild-type cells
- macrophage migration through artificial extracellular matrix is decreased 60% compared with wild-type cells

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Lyz2^tm1(cre)Ifo/Lyz2⁺
involves: 129P2/OlaHsd 129S1/Sv 129X1/SvJ * C57BL/6

mortality/aging

decreased sensitivity to xenobiotic induced morbidity/mortality
- in LPS-treated mice compared with similarly treated wild-type mice

immune system phenotype

decreased interleukin-1 alpha secretion
- 4 hours after LPS treatment

decreased interleukin-1 beta secretion
- 4 hours after LPS treatment

decreased interleukin-12 secretion
- 4 hours after LPS treatment

decreased interleukin-6 secretion
- 1.5 hrs after LPS treatment

decreased susceptibility to endotoxin shock
- LPS-treated mice exhibit less hypothermia, hypotension, and mortality; improved hemodynamic parameter, shock index, and heart rate to systolic blood pressure; and decreased macrophage cytokine production (TNF-alpha, IL6, IL12, IL1a, and IL1b) compared with similarly treated wild-type miceh similarly treated wild-type mice

decreased tumor necrosis factor secretion
- 1.5 and 4 hrs after LPS treatment

homeostasis/metabolism phenotype

abnormal body temperature
- LPS-treated mice develop less hypothermia compared with similarly treated wild-type mice

decreased sensitivity to xenobiotic induced morbidity/mortality
- in LPS-treated mice compared with similarly treated wild-type mice

cardiovascular system phenotype

abnormal systemic arterial blood pressure
- LPS-treated mice develop less hypotension compared with similarly treated wild-type mice

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Vhl^tm1Jae/Vhl^tm1Jae Tg(Alb-cre)21Mgn/0
involves: 129 * BALB/c * C57BL/6 * DBA

liver/biliary system phenotype

hepatic steatosis
- severe steatosis

cardiovascular system phenotype

abnormal vasodilation
- hepatic vascular angiectasia

increased vascular endothelial cell number
- proliferation of endothelial cells in hepatic blood vessels

muscle phenotype

abnormal vasodilation
- hepatic vascular angiectasia

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(Ckmm-cre)5Khn/?
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N

muscle phenotype

abnormal muscle physiology
- increase in muscle damage following exercise

homeostasis/metabolism phenotype

abnormal exercise endurance
- endurance decreased over 4 consecutive days of daily treadmill running
- increased endurance in swim tests and in the first session of running uphill (concentric exercise) but decreased endurance when running downhill (eccentric exercise)

abnormal glucose homeostasis
- significant decrease in lactate accumulation after exercise

increased circulating creatine kinase level
- increased serum levels of the MM isoform of creatine kinase 1 day after exercise

nervous system phenotype

abnormal innervation pattern to muscle
- slight but statistically significant decrease in type IIa fibers in the soleus

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(Itgax-cre)1-1Reiz/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA

immune system phenotype

abnormal dendritic cell number
- bone marrow dendritic cells (BMDCs) differentiated under hypoxic conditions display reduced growth (proliferation) compared to control cells grown in hypoxia or mutant and control cells grown under normoxic (21% oxygen) conditions

abnormal leukocyte migration
- fewer mutant BMDCs generated under hypoxic conditions migrate toward CCL19 in a transwell chamber assay than control cells grown under hypoxic conditions; migration toward CXCL12 is not different from controls under hypoxic or normoxic conditions
- mutant BMDCs generated under hypoxic conditions injected into mouse footpads show reduced migration to popliteal lymph nodes compared to control BMDCs grown under hypoxic conditions; mutant and control BMDCs generated under normoxic conditions migrate equally well to draining lymph nodes while control cells generated under hypoxia display enhanced migration relative to control cells from normoxic cultures, indicating migration under under hypoxic conditons is dependent on Hif1aally well to draining lymph nodes while control cells generated under hypoxia display enhanced migration relative to control cells from normoxic cultures, indicating migration under under hypoxic conditons is dependent on Hif1a

immune system phenotype
- bone marrow derived dendritic cells (BMDCs) cultured under hypoxic conditions (1% oxygen) show upregulation of maturation markers such as MHCII, CD86, with CD80 only slightly enhanced; control BMDCs grown in hypoxic conditions show similar enhanced maturation markerstion markers
- production of Il12p70, Il10, Il6, and Il23 is decreased in mutant and control BMDCs under hypoxic conditions, with Il22 upregulated compared to normoxic cells; mutant and control BMDCs generated under hypoxic conditions produce less TNFalpha and Il-1beta than cells under normoxic conditionsthan cells under normoxic conditions
- stimulation by LPS does not further enhance expression of maturation markers as it does in BMDCs grown under normoxic conditions

cellular phenotype

abnormal cell physiology
- reduced amounts of ATP are detected in lysates of mutant BMDCs cultured under hypoxic conditions compared to control cells under hypoxia suggesting an energy metabolism defect with Hif1a deletion

abnormal leukocyte migration
- fewer mutant BMDCs generated under hypoxic conditions migrate toward CCL19 in a transwell chamber assay than control cells grown under hypoxic conditions; migration toward CXCL12 is not different from controls under hypoxic or normoxic conditions
- mutant BMDCs generated under hypoxic conditions injected into mouse footpads show reduced migration to popliteal lymph nodes compared to control BMDCs grown under hypoxic conditions; mutant and control BMDCs generated under normoxic conditions migrate equally well to draining lymph nodes while control cells generated under hypoxia display enhanced migration relative to control cells from normoxic cultures, indicating migration under under hypoxic conditons is dependent on Hif1aally well to draining lymph nodes while control cells generated under hypoxia display enhanced migration relative to control cells from normoxic cultures, indicating migration under under hypoxic conditons is dependent on Hif1a

hematopoietic system phenotype

abnormal dendritic cell number
- bone marrow dendritic cells (BMDCs) differentiated under hypoxic conditions display reduced growth (proliferation) compared to control cells grown in hypoxia or mutant and control cells grown under normoxic (21% oxygen) conditions

abnormal leukocyte migration
- fewer mutant BMDCs generated under hypoxic conditions migrate toward CCL19 in a transwell chamber assay than control cells grown under hypoxic conditions; migration toward CXCL12 is not different from controls under hypoxic or normoxic conditions
- mutant BMDCs generated under hypoxic conditions injected into mouse footpads show reduced migration to popliteal lymph nodes compared to control BMDCs grown under hypoxic conditions; mutant and control BMDCs generated under normoxic conditions migrate equally well to draining lymph nodes while control cells generated under hypoxia display enhanced migration relative to control cells from normoxic cultures, indicating migration under under hypoxic conditons is dependent on Hif1aally well to draining lymph nodes while control cells generated under hypoxia display enhanced migration relative to control cells from normoxic cultures, indicating migration under under hypoxic conditons is dependent on Hif1a

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(MMTV-cre)1Mam/0
involves: 129S1/Sv * 129X1/SvJ * CD-1 * FVB

endocrine/exocrine gland phenotype

abnormal lactation
- female mice fail to secrete sufficient milk to support their offspring, most of whom are runted and die by P15

abnormal mammary gland alveolus morphology
- alveolar differentiation during pregnancy is blocked
- alveolar lumens are small compared to in wild-type mice and fail to secret milk
- by day 15 of pregnancy, alveoli are smaller than normal with more prominent surrounding connective tissue than in wild-type mice
- however, cell proliferation is normal

abnormal mammary gland epithelium morphology
- by day 15 of pregnancy, mammary gland epithelium lack the lacy appearance of wild-type epithelium
- during lactation, epithelial cells trap milk and fat unlike in wild-type mice
- transplanted mammary epithelium fails to grow in mice expressing the wild-type protein

abnormal mammary gland morphology
- at day 1 of lactation, mammary glands have fewer alveoli, fewer milk granules, and increased trapping of lipid droplets within epithelial cells compared to in wild-type mice
- during lactation, mammary gland wet weight is decreased 50% compared to in wild-type mice

abnormal milk composition
- milk water content is decreased while milk sodium and chloride ion contents are increased compared to in wild-type mice

cardiovascular system phenotype

cardiovascular system phenotype
- microvessel patterning and vascular density in the mammary gland are normal

integument phenotype

abnormal lactation
- female mice fail to secrete sufficient milk to support their offspring, most of whom are runted and die by P15

abnormal mammary gland alveolus morphology
- alveolar differentiation during pregnancy is blocked
- alveolar lumens are small compared to in wild-type mice and fail to secret milk
- by day 15 of pregnancy, alveoli are smaller than normal with more prominent surrounding connective tissue than in wild-type mice
- however, cell proliferation is normal

abnormal mammary gland epithelium morphology
- by day 15 of pregnancy, mammary gland epithelium lack the lacy appearance of wild-type epithelium
- during lactation, epithelial cells trap milk and fat unlike in wild-type mice
- transplanted mammary epithelium fails to grow in mice expressing the wild-type protein

abnormal mammary gland morphology
- at day 1 of lactation, mammary glands have fewer alveoli, fewer milk granules, and increased trapping of lipid droplets within epithelial cells compared to in wild-type mice
- during lactation, mammary gland wet weight is decreased 50% compared to in wild-type mice

abnormal milk composition
- milk water content is decreased while milk sodium and chloride ion contents are increased compared to in wild-type mice

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0
involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6

mortality/aging

neonatal lethality, incomplete penetrance
- 85% of mice die within an hour of birth when exposed to doxycycline 4 of 6 days prior to parturition
- all mice die within an hour of birth when exposed to doxycycline 8 days prior to parturition

respiratory system phenotype

abnormal pulmonary alveolus epithelial cell morphology
- when mice are exposed to doxycycline prior to parturition, the alveolar surface is lined with immature pneumocytes unlike in wild-type mice

abnormal pulmonary alveolus morphology
- when mice are exposed to doxycycline prior to parturition, mice exhibit reduced alveolar airspaces unlike wild-type mice

abnormal surfactant secretion
- when mice are exposed to doxycycline prior to parturition

abnormal type II pneumocyte morphology
- when mice are exposed to doxycycline prior to parturition, the alveolar septa has only a few scattered type II cells unlike in wild-type mice

atelectasis
- at birth when mice are exposed to doxycycline prior to parturition

increased lung weight
- at birth when mice are exposed to doxycycline prior to parturition

respiratory distress
- at birth when mice are exposed to doxycycline prior to parturition

thick pulmonary interalveolar septum
- at birth when mice are exposed to doxycycline prior to parturition

homeostasis/metabolism phenotype

cyanosis
- at birth when mice are exposed to doxycycline prior to parturition

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(Tek-cre)1Ywa/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL

cardiovascular system phenotype

abnormal vascular endothelial cell migration
- endothelial cells exhibit reduced VEGF-directed migration in hypoxic culture conditions compared with similarly treated wild-type cells
- endothelial cells exhibit reduced VEGF-induced migration in matrigel compared with similarly treated wild-type mice
- however, random migration is normal

decreased angiogenesis
- endothelial cells exhibit reduced VEGF-induced angiogenesis compared with similarly treated wild-type mice
- transplanted tumors exhibit a 50% in tumor vessel density compared with tumors transplanted into wild-type mice
- under hypoxic culture conditions, endothelial cells exhibit reduced VEGF-induced capillary structure formation compared with similarly treated wild-type cells

decreased vascular endothelial cell proliferation
- VEGF-induced endothelial cell proliferation in matrigel is reduced compared with wild-type mice

neoplasm

decreased tumor growth/size
- transplanted tumors are 60% lighter than those transplanted into wild-type mice with severe central necrosis due to decreased tumor angiogenesis

homeostasis/metabolism phenotype

delayed wound healing
- with reduced capillary sprouting

cellular phenotype

abnormal vascular endothelial cell migration
- endothelial cells exhibit reduced VEGF-directed migration in hypoxic culture conditions compared with similarly treated wild-type cells
- endothelial cells exhibit reduced VEGF-induced migration in matrigel compared with similarly treated wild-type mice
- however, random migration is normal

decreased vascular endothelial cell proliferation
- VEGF-induced endothelial cell proliferation in matrigel is reduced compared with wild-type mice

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S1/Sv * 129X1/SvJ

immune system phenotype

immune system phenotype
- hematocrit levels are normal in mutants; mutants do not develop anemia

References

Ryan HE; Poloni M; McNulty W; Elson D; Gassmann M; Arbeit JM; Johnson RS. 2000. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res 60(15):4010-5. PubMed: 10945599 MGI: J:78980

Additional - Hif1a^tm3Rsjo related

Adam J; Hatipoglu E; O'Flaherty L; Ternette N; Sahgal N; Lockstone H; Baban D; Nye E; Stamp GW; Wolhuter K; Stevens M; Fischer R; Carmeliet P; Maxwell PH; Pugh CW; Frizzell N; Soga T; Kessler BM; El-Bahrawy M; Ratcliffe PJ; Pollard PJ. 2011. Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling. Cancer Cell 20(4):524-37. PubMed: 22014577 MGI: J:177485
Albers J; Danzer C; Rechsteiner M; Lehmann H; Brandt LP; Hejhal T; Catalano A; Busenhart P; Goncalves AF; Brandt S; Bode PK; Bode-Lesniewska B; Wild PJ; Frew IJ. 2015. A versatile modular vector system for rapid combinatorial mammalian genetics. J Clin Invest 125(4):1603-19. PubMed: 25751063 MGI: J:222097
Amarilio R; Viukov SV; Sharir A; Eshkar-Oren I; Johnson RS; Zelzer E. 2007. HIF1{alpha} regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Development 134(21):3917-28. PubMed: 17913788 MGI: J:126336
Aro E; Khatri R; Gerard-O'Riley R; Mangiavini L; Myllyharju J; Schipani E. 2012. Hypoxia-inducible factor-1 (HIF-1) but not HIF-2 is essential for hypoxic induction of collagen prolyl 4-hydroxylases in primary newborn mouse epiphyseal growth plate chondrocytes. J Biol Chem 287(44):37134-44. PubMed: 22930750 MGI: J:214713
Arsenault PR; Pei F; Lee R; Kerestes H; Percy MJ; Keith B; Simon MC; Lappin TR; Khurana TS; Lee FS. 2013. A Knock-in Mouse Model of Human PHD2 Gene-associated Erythrocytosis Establishes a Haploinsufficiency Mechanism. J Biol Chem 288(47):33571-84. PubMed: 24121508 MGI: J:202737
Baranova O; Miranda LF; Pichiule P; Dragatsis I; Johnson RS; Chavez JC. 2007. Neuron-specific inactivation of the hypoxia inducible factor 1alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci 27(23):6320-32. PubMed: 17554006 MGI: J:121971
Bayele HK; Peyssonnaux C; Giatromanolaki A; Arrais-Silva WW; Mohamed HS; Collins H; Giorgio S; Koukourakis M; Johnson RS; Blackwell JM; Nizet V; Srai SK. 2007. HIF-1 regulates heritable variation and allele expression phenotypes of the macrophage immune response gene SLC11A1 from a Z-DNA forming microsatellite. Blood 110(8):3039-48. PubMed: 17606764 MGI: J:148905
Bentovim L; Amarilio R; Zelzer E. 2012. HIF1alpha is a central regulator of collagen hydroxylation and secretion under hypoxia during bone development. Development 139(23):4473-83. PubMed: 23095889 MGI: J:189214
Biju MP; Neumann AK; Bensinger SJ; Johnson RS; Turka LA; Haase VH. 2004. Vhlh gene deletion induces hif-1-mediated cell death in thymocytes. Mol Cell Biol 24(20):9038-47. PubMed: 15456877 MGI: J:93322
Bouaziz W; Sigaux J; Modrowski D; Devignes CS; Funck-Brentano T; Richette P; Ea HK; Provot S; Cohen-Solal M; Hay E. 2016. Interaction of HIF1alpha and beta-catenin inhibits matrix metalloproteinase 13 expression and prevents cartilage damage in mice. Proc Natl Acad Sci U S A 113(19):5453-8. PubMed: 27122313 MGI: J:232188
Boutin AT; Weidemann A; Fu Z; Mesropian L; Gradin K; Jamora C; Wiesener M; Eckardt KU; Koch CJ; Ellies LG; Haddad G; Haase VH; Simon MC; Poellinger L; Powell FL; Johnson RS. 2008. Epidermal sensing of oxygen is essential for systemic hypoxic response. Cell 133(2):223-34. PubMed: 18423195 MGI: J:145307
Bryant AJ; Carrick RP; McConaha ME; Jones BR; Shay SD; Moore CS; Blackwell TR; Gladson S; Penner NL; Burman A; Tanjore H; Hemnes AR; Karwandyar AK; Polosukhin VV; Talati MA; Dong HJ; Gleaves LA; Carrier EJ; Gaskill C; Scott EW; Majka SM; Fessel JP; Haase VH; West JD; Blackwell TS; Lawson WE. 2016. Endothelial HIF signaling regulates pulmonary fibrosis-associated pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 310(3):L249-62. PubMed: 26637636 MGI: J:233178
Candelario KM; Shuttleworth CW; Cunningham LA. 2013. Neural stem/progenitor cells display a low requirement for oxidative metabolism independent of hypoxia inducible factor-1alpha expression. J Neurochem 125(3):420-9. PubMed: 23410250 MGI: J:225064
Cantley J; Selman C; Shukla D; Abramov AY; Forstreuter F; Esteban MA; Claret M; Lingard SJ; Clements M; Harten SK; Asare-Anane H; Batterham RL; Herrera PL; Persaud SJ; Duchen MR; Maxwell PH; Withers DJ. 2009. Deletion of the von Hippel-Lindau gene in pancreatic beta cells impairs glucose homeostasis in mice. J Clin Invest 119(1):125-35. PubMed: 19065050 MGI: J:144713
Caprara C; Thiersch M; Lange C; Joly S; Samardzija M; Grimm C. 2011. HIF1A Is Essential for the Development of the Intermediate Plexus of the Retinal Vasculature. Invest Ophthalmol Vis Sci 52(5):2109-17. PubMed: 21212189 MGI: J:171540
Chavez JC; Baranova O; Lin J; Pichiule P. 2006. The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J Neurosci 26(37):9471-81. PubMed: 16971531 MGI: J:144667
Chen Y; Doughman YQ; Gu S; Jarrell A; Aota S; Cvekl A; Watanabe M; Dunwoodie SL; Johnson RS; van Heyningen V; Kleinjan DA; Beebe DC; Yang YC. 2008. Cited2 is required for the proper formation of the hyaloid vasculature and for lens morphogenesis. Development 135(17):2939-48. PubMed: 18653562 MGI: J:139006
Cho Y; Shin JE; Ewan EE; Oh YM; Pita-Thomas W; Cavalli V. 2015. Activating Injury-Responsive Genes with Hypoxia Enhances Axon Regeneration through Neuronal HIF-1alpha. Neuron 88(4):720-34. PubMed: 26526390 MGI: J:228750
Chou TF; Chuang YT; Hsieh WC; Chang PY; Liu HY; Mo ST; Hsu TS; Miaw SC; Chen RH; Kimchi A; Lai MZ. 2016. Tumour suppressor death-associated protein kinase targets cytoplasmic HIF-1alpha for Th17 suppression. Nat Commun 7:11904. PubMed: 27312851 MGI: J:239885
Ciofani M; Madar A; Galan C; Sellars M; Mace K; Pauli F; Agarwal A; Huang W; Parkurst CN; Muratet M; Newberry KM; Meadows S; Greenfield A; Yang Y; Jain P; Kirigin FK; Birchmeier C; Wagner EF; Murphy KM; Myers RM; Bonneau R; Littman DR. 2012. A validated regulatory network for th17 cell specification. Cell 151(2):289-303. PubMed: 23021777 MGI: J:188993
Clambey ET; McNamee EN; Westrich JA; Glover LE; Campbell EL; Jedlicka P; de Zoeten EF; Cambier JC; Stenmark KR; Colgan SP; Eltzschig HK. 2012. Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc Natl Acad Sci U S A 109(41):E2784-93. PubMed: 22988108 MGI: J:190110
Clever D; Roychoudhuri R; Constantinides MG; Askenase MH; Sukumar M; Klebanoff CA; Eil RL; Hickman HD; Yu Z; Pan JH; Palmer DC; Phan AT; Goulding J; Gattinoni L; Goldrath AW; Belkaid Y; Restifo NP. 2016. Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche. Cell 166(5):1117-1131.e14. PubMed: 27565342 MGI: J:234541
Cowburn AS; Alexander LE; Southwood M; Nizet V; Chilvers ER; Johnson RS. 2014. Epidermal Deletion of HIF-2alpha Stimulates Wound Closure. J Invest Dermatol 134(3):801-8. PubMed: 24037341 MGI: J:206050
Cowburn AS; Crosby A; Macias D; Branco C; Colaco RD; Southwood M; Toshner M; Crotty Alexander LE; Morrell NW; Chilvers ER; Johnson RS. 2016. HIF2alpha-arginase axis is essential for the development of pulmonary hypertension. Proc Natl Acad Sci U S A 113(31):8801-6. PubMed: 27432976 MGI: J:234394
Cowburn AS; Takeda N; Boutin AT; Kim JW; Sterling JC; Nakasaki M; Southwood M; Goldrath AW; Jamora C; Nizet V; Chilvers ER; Johnson RS. 2013. HIF isoforms in the skin differentially regulate systemic arterial pressure. Proc Natl Acad Sci U S A 110(43):17570-5. PubMed: 24101470 MGI: J:201979
Cramer T; Yamanishi Y; Clausen BE; Forster I; Pawlinski R; Mackman N; Haase VH; Jaenisch R; Corr M; Nizet V; Firestein GS; Gerber HP; Ferrara N; Johnson RS. 2003. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112(5):645-57. PubMed: 12628185 MGI: J:107682
Dang EV; Barbi J; Yang HY; Jinasena D; Yu H; Zheng Y; Bordman Z; Fu J; Kim Y; Yen HR; Luo W; Zeller K; Shimoda L; Topalian SL; Semenza GL; Dang CV; Pardoll DM; Pan F. 2011. Control of T(H)17/T(reg) Balance by Hypoxia-Inducible Factor 1. Cell 146(5):772-84. PubMed: 21871655 MGI: J:176230
Diebold I; Petry A; Sabrane K; Djordjevic T; Hess J; Gorlach A. 2012. The HIF1 target gene NOX2 promotes angiogenesis through urotensin-II. J Cell Sci 125(Pt 4):956-64. PubMed: 22399808 MGI: J:197690
Doedens AL; Phan AT; Stradner MH; Fujimoto JK; Nguyen JV; Yang E; Johnson RS; Goldrath AW. 2013. Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. Nat Immunol 14(11):1173-82. PubMed: 24076634 MGI: J:208201
Du J; Chen Y; Li Q; Han X; Cheng C; Wang Z; Danielpour D; Dunwoodie SL; Bunting KD; Yang YC. 2012. HIF-1alpha deletion partially rescues defects of hematopoietic stem cell quiescence caused by Cited2 deficiency. Blood 119(12):2789-98. PubMed: 22308296 MGI: J:182527
Eckle T; Brodsky K; Bonney M; Packard T; Han J; Borchers CH; Mariani TJ; Kominsky DJ; Mittelbronn M; Eltzschig HK. 2013. HIF1A reduces acute lung injury by optimizing carbohydrate metabolism in the alveolar epithelium. PLoS Biol 11(9):e1001665. PubMed: 24086109 MGI: J:201805
Eckle T; Hartmann K; Bonney S; Reithel S; Mittelbronn M; Walker LA; Lowes BD; Han J; Borchers CH; Buttrick PM; Kominsky DJ; Colgan SP; Eltzschig HK. 2012. Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat Med 18(5):774-82. PubMed: 22504483 MGI: J:183926
Eckle T; Kewley EM; Brodsky KS; Tak E; Bonney S; Gobel M; Anderson D; Glover LE; Riegel AK; Colgan SP; Eltzschig HK. 2014. Identification of hypoxia-inducible factor HIF-1A as transcriptional regulator of the A2B adenosine receptor during acute lung injury. J Immunol 192(3):1249-56. PubMed: 24391213 MGI: J:207297
Eisinger-Mathason TS; Zhang M; Qiu Q; Skuli N; Nakazawa MS; Karakasheva T; Mucaj V; Shay JE; Stangenberg L; Sadri N; Pure E; Yoon SS; Kirsch DG; Simon MC. 2013. Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis. Cancer Discov 3(10):1190-205. PubMed: 23906982 MGI: J:204376
Elorza A; Soro-Arnaiz I; Melendez-Rodriguez F; Rodriguez-Vaello V; Marsboom G; de Carcer G; Acosta-Iborra B; Albacete-Albacete L; Ordonez A; Serrano-Oviedo L; Gimenez-Bachs JM; Vara-Vega A; Salinas A; Sanchez-Prieto R; Martin del Rio R; Sanchez-Madrid F;Malumbres M; Landazuri MO; Aragones J. 2012. HIF2alpha acts as an mTORC1 activator through the amino acid carrier SLC7A5. Mol Cell 48(5):681-91. PubMed: 23103253 MGI: J:194004
Fan D; Coughlin LA; Neubauer MM; Kim J; Kim MS; Zhan X; Simms-Waldrip TR; Xie Y; Hooper LV; Koh AY. 2015. Activation of HIF-1alpha and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat Med 21(7):808-14. PubMed: 26053625 MGI: J:224763
Fang HY; Hughes R; Murdoch C; Coffelt SB; Biswas SK; Harris AL; Johnson RS; Imityaz HZ; Simon MC; Fredlund E; Greten FR; Rius J; Lewis CE. 2009. Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 114(4):844-59. PubMed: 19454749 MGI: J:150747
Farsijani NM; Liu Q; Kobayashi H; Davidoff O; Sha F; Fandrey J; Ikizler TA; O'Connor PM; Haase VH. 2016. Renal epithelium regulates erythropoiesis via HIF-dependent suppression of erythropoietin. J Clin Invest 126(4):1425-37. PubMed: 26927670 MGI: J:234569
Forristal CE; Nowlan B; Jacobsen RN; Barbier V; Walkinshaw G; Walkley CR; Winkler IG; Levesque JP. 2015. HIF-1alpha is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1alpha. Leukemia 29(6):1366-78. PubMed: 25578474 MGI: J:221975
Franke K; Kalucka J; Mamlouk S; Singh RP; Muschter A; Weidemann A; Iyengar V; Jahn S; Wieczorek K; Geiger K; Muders M; Sykes AM; Poitz DM; Ripich T; Otto T; Bergmann S; Breier G; Baretton G; Fong GH; Greaves DR; Bornstein S; Chavakis T; Fandrey J; Gassmann M; Wielockx B. 2013. HIF-1alpha is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2alpha-induced excessive erythropoiesis. Blood 121(8):1436-45. PubMed: 23264599 MGI: J:194598
Garcia CM; Shui YB; Kamath M; DeVillar J; Johnson RS; Gerber HP; Ferrara N; Robinson ML; Beebe DC. 2009. The function of VEGF-A in lens development: formation of the hyaloid capillary network and protection against transient nuclear cataracts. Exp Eye Res 88(2):270-6. PubMed: 18782574 MGI: J:146379
Glick D; Zhang W; Beaton M; Marsboom G; Gruber M; Simon MC; Hart J; Dorn GW 2nd; Brady MJ; Macleod KF. 2012. BNip3 regulates mitochondrial function and lipid metabolism in the liver. Mol Cell Biol 32(13):2570-84. PubMed: 22547685 MGI: J:186671
Greenwood KK; Proper SP; Saini Y; Bramble LA; Jackson-Humbles DN; Wagner JG; Harkema JR; LaPres JJ. 2012. Neonatal epithelial hypoxia inducible factor-1alpha expression regulates the response of the lung to experimental asthma. Am J Physiol Lung Cell Mol Physiol 302(5):L455-62. PubMed: 22180657 MGI: J:183445
Gruber M; Hu CJ; Johnson RS; Brown EJ; Keith B; Simon MC. 2007. Acute postnatal ablation of Hif-2alpha results in anemia. Proc Natl Acad Sci U S A 104(7):2301-6. PubMed: 17284606 MGI: J:119731
Guimaraes-Camboa N; Stowe J; Aneas I; Sakabe N; Cattaneo P; Henderson L; Kilberg MS; Johnson RS; Chen J; McCulloch AD; Nobrega MA; Evans SM; Zambon AC. 2015. HIF1alpha Represses Cell Stress Pathways to Allow Proliferation of Hypoxic Fetal Cardiomyocytes. Dev Cell 33(5):507-21. PubMed: 26028220 MGI: J:239361
Guitart AV; Subramani C; Armesilla-Diaz A; Smith G; Sepulveda C; Gezer D; Vukovic M; Dunn K; Pollard P; Holyoake TL; Enver T; Ratcliffe PJ; Kranc KR. 2013. Hif-2alpha is not essential for cell-autonomous hematopoietic stem cell maintenance. Blood 122(10):1741-5. PubMed: 23894152 MGI: J:202361
Hanna SC; Krishnan B; Bailey ST; Moschos SJ; Kuan PF; Shimamura T; Osborne LD; Siegel MB; Duncan LM; O'Brien ET 3rd; Superfine R; Miller CR; Simon MC; Wong KK; Kim WY. 2013. HIF1alpha and HIF2alpha independently activate SRC to promote melanoma metastases. J Clin Invest 123(5):2078-93. PubMed: 23563312 MGI: J:201460
Harms KM; Li L; Cunningham LA. 2010. Murine neural stem/progenitor cells protect neurons against ischemia by HIF-1alpha-regulated VEGF signaling. PLoS One 5(3):e9767. PubMed: 20339541 MGI: J:158881
Hart ML; Grenz A; Gorzolla IC; Schittenhelm J; Dalton JH; Eltzschig HK. 2011. Hypoxia-Inducible Factor-1{alpha}-Dependent Protection from Intestinal Ischemia/Reperfusion Injury Involves Ecto-5'-Nucleotidase (CD73) and the A2B Adenosine Receptor. J Immunol 186(7):4367-74. PubMed: 21357264 MGI: J:170696
Helton R; Cui J; Scheel JR; Ellison JA; Ames C; Gibson C; Blouw B; Ouyang L; Dragatsis I; Zeitlin S; Johnson RS; Lipton SA; Barlow C. 2005. Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage. J Neurosci 25(16):4099-107. PubMed: 15843612 MGI: J:98637
Herr B; Zhou J; Werno C; Menrad H; Namgaladze D; Weigert A; Dehne N; Brune B. 2009. The supernatant of apoptotic cells causes transcriptional activation of hypoxia-inducible factor-1alpha in macrophages via sphingosine-1-phosphate and transforming growth factor-beta. Blood 114(10):2140-8. PubMed: 19549990 MGI: J:152258
Higashiyama M; Hokari R; Hozumi H; Kurihara C; Ueda T; Watanabe C; Tomita K; Nakamura M; Komoto S; Okada Y; Kawaguchi A; Nagao S; Suematsu M; Goda N; Miura S. 2012. HIF-1 in T cells ameliorated dextran sodium sulfate-induced murine colitis. J Leukoc Biol 91(6):901-9. PubMed: 22457366 MGI: J:184909
Higgins DF; Biju MP; Akai Y; Wutz A; Johnson RS; Haase VH. 2004. Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol 287(6):F1223-32. PubMed: 15315937 MGI: J:95664
Higgins DF; Kimura K; Bernhardt WM; Shrimanker N; Akai Y; Hohenstein B; Saito Y; Johnson RS; Kretzler M; Cohen CD; Eckardt KU; Iwano M; Haase VH. 2007. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 117(12):3810-20. PubMed: 18037992 MGI: J:130751
Hoppe G; Lee TJ; Yoon S; Yu M; Peachey NS; Rayborn M; Zutel MJ; Trichonas G; Au J; Sears JE. 2014. Inducing a visceral organ to protect a peripheral capillary bed: stabilizing hepatic HIF-1alpha prevents oxygen-induced retinopathy. Am J Pathol 184(6):1890-9. PubMed: 24731446 MGI: J:211093
Hoppe G; Yoon S; Gopalan B; Savage AR; Brown R; Case K; Vasanji A; Chan ER; Silver RB; Sears JE. 2016. Comparative systems pharmacology of HIF stabilization in the prevention of retinopathy of prematurity. Proc Natl Acad Sci U S A 113(18):E2516-25. PubMed: 27091985 MGI: J:232210
Huang TQ; Wang Y; Ebrahem Q; Chen Y; Cheng C; Doughman YQ; Watanabe M; Dunwoodie SL; Yang YC. 2012. Deletion of HIF-1alpha partially rescues the abnormal hyaloid vascular system in Cited2 conditional knockout mouse eyes. Mol Vis 18:1260-70. PubMed: 22665973 MGI: J:191613
Huang Y; Hickey RP; Yeh JL; Liu D; Dadak A; Young LH; Johnson RS; Giordano FJ. 2004. Cardiac myocyte-specific HIF-1alpha deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart. FASEB J 18(10):1138-40. PubMed: 15132980 MGI: J:118455
Huang Y; Lei L; Liu D; Jovin I; Russell R; Johnson RS; Di Lorenzo A; Giordano FJ. 2012. Normal glucose uptake in the brain and heart requires an endothelial cell-specific HIF-1alpha-dependent function. Proc Natl Acad Sci U S A 109(43):17478-83. PubMed: 23047702 MGI: J:190364
Ikejiri A; Nagai S; Goda N; Kurebayashi Y; Osada-Oka M; Takubo K; Suda T; Koyasu S. 2012. Dynamic regulation of Th17 differentiation by oxygen concentrations. Int Immunol 24(3):137-46. PubMed: 22207131 MGI: J:182569
Imanirad P; Solaimani Kartalaei P; Crisan M; Vink C; Yamada-Inagawa T; de Pater E; Kurek D; Kaimakis P; van der Linden R; Speck N; Dzierzak E. 2014. HIF1alpha is a regulator of hematopoietic progenitor and stem cell development in hypoxic sites of the mouse embryo. Stem Cell Res 12(1):24-35. PubMed: 24141110 MGI: J:205140
Jiang X; Khan MA; Tian W; Beilke J; Natarajan R; Kosek J; Yoder MC; Semenza GL; Nicolls MR. 2011. Adenovirus-mediated HIF-1alpha gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection. J Clin Invest 121(6):2336-49. PubMed: 21606594 MGI: J:174019
Kalucka J; Ettinger A; Franke K; Mamlouk S; Singh RP; Farhat K; Muschter A; Olbrich S; Breier G; Katschinski DM; Huttner W; Weidemann A; Wielockx B. 2013. Loss of epithelial hypoxia-inducible factor prolyl hydroxylase 2 accelerates skin wound healing in mice. Mol Cell Biol 33(17):3426-38. PubMed: 23798557 MGI: J:204713
Kapitsinou PP; Liu Q; Unger TL; Rha J; Davidoff O; Keith B; Epstein JA; Moores SL; Erickson-Miller CL; Haase VH. 2010. Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. Blood 116(16):3039-48. PubMed: 20628150 MGI: J:165868
Kapitsinou PP; Rajendran G; Astleford L; Michael M; Schonfeld MP; Fields T; Shay S; French JL; West J; Haase VH. 2016. The Endothelial Prolyl-4-Hydroxylase Domain 2/Hypoxia-Inducible Factor 2 Axis Regulates Pulmonary Artery Pressure in Mice. Mol Cell Biol 36(10):1584-94. PubMed: 26976644 MGI: J:236191
Kapitsinou PP; Sano H; Michael M; Kobayashi H; Davidoff O; Bian A; Yao B; Zhang MZ; Harris RC; Duffy KJ; Erickson-Miller CL; Sutton TA; Haase VH. 2014. Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury. J Clin Invest 124(6):2396-409. PubMed: 24789906 MGI: J:212930
Karhausen J; Furuta GT; Tomaszewski JE; Johnson RS; Colgan SP; Haase VH. 2004. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 114(8):1098-106. PubMed: 15489957 MGI: J:93476
Kenchegowda D; Natale B; Lemus MA; Natale DR; Fisher SA. 2017. Inactivation of maternal Hif-1alpha at mid-pregnancy causes placental defects and deficits in oxygen delivery to the fetal organs under hypoxic stress. Dev Biol 422(2):171-185. PubMed: 27940158 MGI: J:239312
Kim JW; Evans C; Weidemann A; Takeda N; Lee YS; Stockmann C; Branco-Price C; Brandberg F; Leone G; Ostrowski MC; Johnson RS. 2012. Loss of fibroblast HIF-1alpha accelerates tumorigenesis. Cancer Res 72(13):3187-95. PubMed: 22556263 MGI: J:189318
Kim YM; Barnes EA; Alvira CM; Ying L; Reddy S; Cornfield DN. 2013. Hypoxia-inducible factor-1alpha in pulmonary artery smooth muscle cells lowers vascular tone by decreasing myosin light chain phosphorylation. Circ Res 112(9):1230-3. PubMed: 23513056 MGI: J:213312
Kobayashi H; Gilbert V; Liu Q; Kapitsinou PP; Unger TL; Rha J; Rivella S; Schlondorff D; Haase VH. 2012. Myeloid cell-derived hypoxia-inducible factor attenuates inflammation in unilateral ureteral obstruction-induced kidney injury. J Immunol 188(10):5106-15. PubMed: 22490864 MGI: J:188688
Kocabas F; Zheng J; Thet S; Copeland NG; Jenkins NA; DeBerardinis RJ; Zhang C; Sadek HA. 2012. Meis1 regulates the metabolic phenotype and oxidant defense of hematopoietic stem cells. Blood 120(25):4963-72. PubMed: 22995899 MGI: J:192126
Koh HS; Chang CY; Jeon SB; Yoon HJ; Ahn YH; Kim HS; Kim IH; Jeon SH; Johnson RS; Park EJ. 2015. The HIF-1/glial TIM-3 axis controls inflammation-associated brain damage under hypoxia. Nat Commun 6:6340. PubMed: 25790768 MGI: J:221874
Kohler T; Reizis B; Johnson RS; Weighardt H; Forster I. 2012. Influence of hypoxia-inducible factor 1alpha on dendritic cell differentiation and migration. Eur J Immunol 42(5):1226-36. PubMed: 22539295 MGI: J:187773
Krishnan J; Ahuja P; Bodenmann S; Knapik D; Perriard E; Krek W; Perriard JC. 2008. Essential role of developmentally activated hypoxia-inducible factor 1alpha for cardiac morphogenesis and function. Circ Res 103(10):1139-46. PubMed: 18849322 MGI: J:155281
Krishnan J; Danzer C; Simka T; Ukropec J; Walter KM; Kumpf S; Mirtschink P; Ukropcova B; Gasperikova D; Pedrazzini T; Krek W. 2012. Dietary obesity-associated Hif1alpha activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system. Genes Dev 26(3):259-70. PubMed: 22302938 MGI: J:181338
Krishnan J; Suter M; Windak R; Krebs T; Felley A; Montessuit C; Tokarska-Schlattner M; Aasum E; Bogdanova A; Perriard E; Perriard JC; Larsen T; Pedrazzini T; Krek W. 2009. Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell Metab 9(6):512-24. PubMed: 19490906 MGI: J:149827
Kurihara T; Kubota Y; Ozawa Y; Takubo K; Noda K; Simon MC; Johnson RS; Suematsu M; Tsubota K; Ishida S; Goda N; Suda T; Okano H. 2010. von Hippel-Lindau protein regulates transition from the fetal to the adult circulatory system in retina. Development 137(9):1563-71. PubMed: 20388654 MGI: J:160163
Kurihara T; Westenskow PD; Bravo S; Aguilar E; Friedlander M. 2012. Targeted deletion of Vegfa in adult mice induces vision loss. J Clin Invest 122(11):4213-7. PubMed: 23093773 MGI: J:194014
Kurihara T; Westenskow PD; Krohne TU; Aguilar E; Johnson RS; Friedlander M. 2011. Astrocyte pVHL and HIF-alpha isoforms are required for embryonic-to-adult vascular transition in the eye. J Cell Biol 195(4):689-701. PubMed: 22084310 MGI: J:178823
Kusumbe AP; Ramasamy SK; Adams RH. 2014. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature 507(7492):323-8. PubMed: 24646994 MGI: J:208889
Lange C; Turrero Garcia M; Decimo I; Bifari F; Eelen G; Quaegebeur A; Boon R; Zhao H; Boeckx B; Chang J; Wu C; Le Noble F; Lambrechts D; Dewerchin M; Kuo CJ; Huttner WB; Carmeliet P. 2016. Relief of hypoxia by angiogenesis promotes neural stem cell differentiation by targeting glycolysis. EMBO J 35(9):924-41. PubMed: 26856890 MGI: J:231532
Lange CA; Luhmann UF; Mowat FM; Georgiadis A; West EL; Abrahams S; Sayed H; Powner MB; Fruttiger M; Smith AJ; Sowden JC; Maxwell PH; Ali RR; Bainbridge JW. 2012. Von Hippel-Lindau protein in the RPE is essential for normal ocular growth and vascular development. Development 139(13):2340-50. PubMed: 22627278 MGI: J:185536
Le Moan N; Baeten KM; Rafalski VA; Ryu JK; Rios Coronado PE; Bedard C; Syme C; Davalos D; Akassoglou K. 2015. Hypoxia Inducible Factor-1 in Astrocytes and/or Myeloid Cells Is Not Required for the Development of Autoimmune Demyelinating Disease eNeuro 2(2):. PubMed: 26213713 MGI: J:229425
Lee JH; Elly C; Park Y; Liu YC. 2015. E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1alpha to Maintain Regulatory T Cell Stability and Suppressive Capacity. Immunity 42(6):1062-74. PubMed: 26084024 MGI: J:229111
Lee YS; Kim JW; Osborne O; Oh da Y; Sasik R; Schenk S; Chen A; Chung H; Murphy A; Watkins SM; Quehenberger O; Johnson RS; Olefsky JM. 2014. Increased adipocyte O2 consumption triggers HIF-1alpha, causing inflammation and insulin resistance in obesity. Cell 157(6):1339-52. PubMed: 24906151 MGI: J:214449
Li D; Bai T; Brorson JR. 2011. Adaptation to moderate hypoxia protects cortical neurons against ischemia-reperfusion injury and excitotoxicity independently of HIF-1alpha. Exp Neurol 230(2):302-10. PubMed: 21619879 MGI: J:172731
Li L; Candelario KM; Thomas K; Wang R; Wright K; Messier A; Cunningham LA. 2014. Hypoxia inducible factor-1alpha (HIF-1alpha) is required for neural stem cell maintenance and vascular stability in the adult mouse SVZ. J Neurosci 34(50):16713-9. PubMed: 25505323 MGI: J:218841
Li Y; Lim S; Hoffman D; Aspenstrom P; Federoff HJ; Rempe DA. 2009. HUMMR, a hypoxia- and HIF-1alpha-inducible protein, alters mitochondrial distribution and transport. J Cell Biol 185(6):1065-81. PubMed: 19528298 MGI: J:150420
Liao D; Corle C; Seagroves TN; Johnson RS. 2007. Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Cancer Res 67(2):563-72. PubMed: 17234764 MGI: J:117422
Lin M; Chen Y; Jin J; Hu Y; Zhou KK; Zhu M; Le YZ; Ge J; Johnson RS; Ma JX. 2011. Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Muller cells. Diabetologia :. PubMed: 21360191 MGI: J:170682
Lin M; Hu Y; Chen Y; Zhou KK; Jin J; Zhu M; Le YZ; Ge J; Ma JX. 2012. Impacts of hypoxia-inducible factor-1 knockout in the retinal pigment epithelium on choroidal neovascularization. Invest Ophthalmol Vis Sci 53(10):6197-206. PubMed: 22915031 MGI: J:213965
Liu L; Lu Y; Martinez J; Bi Y; Lian G; Wang T; Milasta S; Wang J; Yang M; Liu G; Green DR; Wang R. 2016. Proinflammatory signal suppresses proliferation and shifts macrophage metabolism from Myc-dependent to HIF1alpha-dependent. Proc Natl Acad Sci U S A 113(6):1564-9. PubMed: 26811453 MGI: J:230492
Liu Q; Davidoff O; Niss K; Haase VH. 2012. Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis. J Clin Invest 122(12):4635-44. PubMed: 23114598 MGI: J:193997
Lukashev D; Klebanov B; Kojima H; Grinberg A; Ohta A; Berenfeld L; Wenger RH; Ohta A; Sitkovsky M. 2006. Cutting edge: hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes. J Immunol 177(8):4962-5. PubMed: 17015677 MGI: J:117857
Lum JJ; Bui T; Gruber M; Gordan JD; Deberardinis RJ; Covello KL; Simon MC; Thompson CB. 2007. The transcription factor HIF-1{alpha} plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev 21(9):1037-49. PubMed: 17437992 MGI: J:121261
Maes C; Araldi E; Haigh K; Khatri R; Van Looveren R; Giaccia AJ; Haigh JJ; Carmeliet G; Schipani E. 2012. VEGF-independent cell-autonomous functions of HIF-1alpha regulating oxygen consumption in fetal cartilage are critical for chondrocyte survival. J Bone Miner Res 27(3):596-609. PubMed: 22162090 MGI: J:233282
Majmundar AJ; Lee DS; Skuli N; Mesquita RC; Kim MN; Yodh AG; Nguyen-McCarty M; Li B; Simon MC. 2015. HIF modulation of Wnt signaling regulates skeletal myogenesis in vivo. Development 142(14):2405-12. PubMed: 26153230 MGI: J:239647
Mamlouk S; Kalucka J; Singh RP; Franke K; Muschter A; Langer A; Jakob C; Gassmann M; Baretton GB; Wielockx B. 2014. Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development. Int J Cancer 134(4):849-58. PubMed: 23913502 MGI: J:231998
Mangiavini L; Merceron C; Araldi E; Khatri R; Gerard-O'Riley R; Wilson TL; Rankin EB; Giaccia AJ; Schipani E. 2014. Loss of VHL in mesenchymal progenitors of the limb bud alters multiple steps of endochondral bone development. Dev Biol 393(1):124-36. PubMed: 24972088 MGI: J:214967
Mangiavini L; Merceron C; Araldi E; Khatri R; Gerard-O'Riley R; Wilson TL; Sandusky G; Abadie J; Lyons KM; Giaccia AJ; Schipani E. 2015. Fibrosis and Hypoxia-Inducible Factor-1alpha-Dependent Tumors of the Soft Tissue on Loss of Von Hippel-Lindau in Mesenchymal Progenitors. Am J Pathol 185(11):3090-101. PubMed: 26348575 MGI: J:226906
Mascanfroni ID; Takenaka MC; Yeste A; Patel B; Wu Y; Kenison JE; Siddiqui S; Basso AS; Otterbein LE; Pardoll DM; Pan F; Priel A; Clish CB; Robson SC; Quintana FJ. 2015. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha. Nat Med 21(6):638-46. PubMed: 26005855 MGI: J:228593
Mason SD; Howlett RA; Kim MJ; Olfert IM; Hogan MC; McNulty W; Hickey RP; Wagner PD; Kahn CR; Giordano FJ; Johnson RS. 2004. Loss of skeletal muscle HIF-1alpha results in altered exercise endurance. PLoS Biol 2(10):e288. PubMed: 15328538 MGI: J:97761
Mason SD; Rundqvist H; Papandreou I; Duh R; McNulty WJ; Howlett RA; Olfert IM; Sundberg CJ; Denko NC; Poellinger L; Johnson RS. 2007. HIF-1alpha in endurance training: suppression of oxidative metabolism. Am J Physiol Regul Integr Comp Physiol 293(5):R2059-69. PubMed: 17855495 MGI: J:145111
Mastrogiannaki M; Matak P; Keith B; Simon MC; Vaulont S; Peyssonnaux C. 2009. HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. J Clin Invest 119(5):1159-66. PubMed: 19352007 MGI: J:149590
Menendez-Montes I; Escobar B; Palacios B; Gomez MJ; Izquierdo-Garcia JL; Flores L; Jimenez-Borreguero LJ; Aragones J; Ruiz-Cabello J; Torres M; Martin-Puig S. 2016. Myocardial VHL-HIF Signaling Controls an Embryonic Metabolic Switch Essential for Cardiac Maturation. Dev Cell 39(6):724-739. PubMed: 27997827 MGI: J:237617
Merceron C; Mangiavini L; Robling A; Wilson TL; Giaccia AJ; Shapiro IM; Schipani E; Risbud MV. 2014. Loss of HIF-1alpha in the notochord results in cell death and complete disappearance of the nucleus pulposus. PLoS One 9(10):e110768. PubMed: 25338007 MGI: J:223545
Miharada K; Karlsson G; Rehn M; Rorby E; Siva K; Cammenga J; Karlsson S. 2011. Cripto regulates hematopoietic stem cells as a hypoxic-niche-related factor through cell surface receptor GRP78. Cell Stem Cell 9(4):330-44. PubMed: 21982233 MGI: J:177654
Milosevic J; Maisel M; Wegner F; Leuchtenberger J; Wenger RH; Gerlach M; Storch A; Schwarz J. 2007. Lack of hypoxia-inducible factor-1 alpha impairs midbrain neural precursor cells involving vascular endothelial growth factor signaling. J Neurosci 27(2):412-21. PubMed: 17215402 MGI: J:117302
Milovanova TN; Bhopale VM; Sorokina EM; Moore JS; Hunt TK; Hauer-Jensen M; Velazquez OC; Thom SR. 2008. Lactate stimulates vasculogenic stem cells via the thioredoxin system and engages an autocrine activation loop involving hypoxia-inducible factor 1. Mol Cell Biol 28(20):6248-61. PubMed: 18710947 MGI: J:140963
Miro-Murillo M; Elorza A; Soro-Arnaiz I; Albacete-Albacete L; Ordonez A; Balsa E; Vara-Vega A; Vazquez S; Fuertes E; Fernandez-Criado C; Landazuri MO; Aragones J. 2011. Acute Vhl Gene Inactivation Induces Cardiac HIF-Dependent Erythropoietin Gene Expression. PLoS One 6(7):e22589. PubMed: 21811636 MGI: J:174924
Miyauchi Y; Sato Y; Kobayashi T; Yoshida S; Mori T; Kanagawa H; Katsuyama E; Fujie A; Hao W; Miyamoto K; Tando T; Morioka H; Matsumoto M; Chambon P; Johnson RS; Kato S; Toyama Y; Miyamoto T. 2013. HIF1alpha is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis. Proc Natl Acad Sci U S A 110(41):16568-73. PubMed: 24023068 MGI: J:202025
Mladenova DN; Dahlstrom JE; Tran PN; Benthani F; Bean EG; Ng I; Pangon L; Currey N; Kohonen-Corish MR. 2015. HIF1alpha deficiency reduces inflammation in a mouse model of proximal colon cancer. Dis Model Mech 8(9):1093-103. PubMed: 26183215 MGI: J:225902
Mochizuki A; Pace A; Rockwell CE; Roth KJ; Chow A; O'Brien KM; Albee R; Kelly K; Towery K; Luyendyk JP; Copple BL. 2014. Hepatic stellate cells orchestrate clearance of necrotic cells in a hypoxia-inducible factor-1alpha-dependent manner by modulating macrophage phenotype in mice. J Immunol 192(8):3847-57. PubMed: 24639359 MGI: J:209999
Morizane Y; Thanos A; Takeuchi K; Murakami Y; Kayama M; Trichonas G; Miller J; Foretz M; Viollet B; Vavvas DG. 2011. AMP-activated Protein Kinase Suppresses Matrix Metalloproteinase-9 Expression in Mouse Embryonic Fibroblasts. J Biol Chem 286(18):16030-8. PubMed: 21402702 MGI: J:172076
Morote-Garcia JC; Rosenberger P; Kuhlicke J; Eltzschig HK. 2008. HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 111(12):5571-80. PubMed: 18309031 MGI: J:136635
Nakamura-Ishizu A; Kurihara T; Okuno Y; Ozawa Y; Kishi K; Goda N; Tsubota K; Okano H; Suda T; Kubota Y. 2012. The formation of an angiogenic astrocyte template is regulated by the neuroretina in a HIF-1-dependent manner. Dev Biol 363(1):106-14. PubMed: 22226979 MGI: J:182708
Nanayakkara G; Alasmari A; Mouli S; Eldoumani H; Quindry J; McGinnis G; Fu X; Berlin A; Peters B; Zhong J; Amin R. 2015. Cardioprotective HIF-1alpha-frataxin signaling against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 309(5):H867-79. PubMed: 26071548 MGI: J:226357
Neumann AK; Yang J; Biju MP; Joseph SK; Johnson RS; Haase VH; Freedman BD; Turka LA. 2005. Hypoxia inducible factor 1 alpha regulates T cell receptor signal transduction. Proc Natl Acad Sci U S A 102(47):17071-6. PubMed: 16286658 MGI: J:103837
O'Reilly VC; Lopes Floro K; Shi H; Chapman BE; Preis JI; James AC; Chapman G; Harvey RP; Johnson RS; Grieve SM; Sparrow DB; Dunwoodie SL. 2014. Gene-environment interaction demonstrates the vulnerability of the embryonic heart. Dev Biol 391(1):99-110. PubMed: 24657234 MGI: J:213653
Ochiai D; Goda N; Hishiki T; Kanai M; Senoo-Matsuda N; Soga T; Johnson RS; Yoshimura Y; Suematsu M. 2011. Disruption of HIF-1alpha in hepatocytes impairs glucose metabolism in diet-induced obesity mice. Biochem Biophys Res Commun 415(3):445-9. PubMed: 22051049 MGI: J:178636
Okabe K; Kobayashi S; Yamada T; Kurihara T; Tai-Nagara I; Miyamoto T; Mukouyama YS; Sato TN; Suda T; Ema M; Kubota Y. 2014. Neurons limit angiogenesis by titrating VEGF in retina. Cell 159(3):584-96. PubMed: 25417109 MGI: J:217533
Paatero I; Seagroves TN; Vaparanta K; Han W; Jones FE; Johnson RS; Elenius K. 2014. Hypoxia-inducible factor-1alpha induces ErbB4 signaling in the differentiating mammary gland. J Biol Chem 289(32):22459-69. PubMed: 24966332 MGI: J:216619
Palazon A; Martinez-Forero I; Teijeira A; Morales-Kastresana A; Alfaro C; Sanmamed MF; Perez-Gracia JL; Penuelas I; Hervas-Stubbs S; Rouzaut A; de Landazuri MO; Jure-Kunkel M; Aragones J; Melero I. 2012. The HIF-1alpha hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy. Cancer Discov 2(7):608-23. PubMed: 22719018 MGI: J:193060
Pantel A; Teixeira A; Haddad E; Wood EG; Steinman RM; Longhi MP. 2014. Direct type I IFN but not MDA5/TLR3 activation of dendritic cells is required for maturation and metabolic shift to glycolysis after poly IC stimulation. PLoS Biol 12(1):e1001759. PubMed: 24409099 MGI: J:207989
Peyssonnaux C; Boutin AT; Zinkernagel AS; Datta V; Nizet V; Johnson RS. 2008. Critical role of HIF-1alpha in keratinocyte defense against bacterial infection. J Invest Dermatol 128(8):1964-8. PubMed: 18323789 MGI: J:141616
Peyssonnaux C; Cejudo-Martin P; Doedens A; Zinkernagel AS; Johnson RS; Nizet V. 2007. Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J Immunol 178(12):7516-9. PubMed: 17548584 MGI: J:148597
Peyssonnaux C; Datta V; Cramer T; Doedens A; Theodorakis EA; Gallo RL; Hurtado-Ziola N; Nizet V; Johnson RS. 2005. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest 115(7):1806-15. PubMed: 16007254 MGI: J:99628
Pfander D; Kobayashi T; Knight MC; Zelzer E; Chan DA; Olsen BR; Giaccia AJ; Johnson RS; Haase VH; Schipani E. 2004. Deletion of Vhlh in chondrocytes reduces cell proliferation and increases matrix deposition during growth plate development. Development 131(10):2497-508. PubMed: 15128677 MGI: J:91056
Platero-Luengo A; Gonzalez-Granero S; Duran R; Diaz-Castro B; Piruat JI; Garcia-Verdugo JM; Pardal R; Lopez-Barneo J. 2014. An o2-sensitive glomus cell-stem cell synapse induces carotid body growth in chronic hypoxia. Cell 156(1-2):291-303. PubMed: 24439383 MGI: J:205562
Pourvali K; Matak P; Latunde-Dada GO; Solomou S; Mastrogiannaki M; Peyssonnaux C; Sharp PA. 2012. Basal expression of copper transporter 1 in intestinal epithelial cells is regulated by hypoxia-inducible factor 2alpha. FEBS Lett 586(16):2423-7. PubMed: 22684009 MGI: J:186999
Pritchett TL; Bader HL; Henderson J; Hsu T. 2015. Conditional inactivation of the mouse von Hippel-Lindau tumor suppressor gene results in wide-spread hyperplastic, inflammatory and fibrotic lesions in the kidney. Oncogene 34(20):2631-9. PubMed: 25023703 MGI: J:221253
Provot S; Zinyk D; Gunes Y; Kathri R; Le Q; Kronenberg HM; Johnson RS; Longaker MT; Giaccia AJ; Schipani E. 2007. Hif-1alpha regulates differentiation of limb bud mesenchyme and joint development. J Cell Biol 177(3):451-64. PubMed: 17470636 MGI: J:134727
Rankin EB; Biju MP; Liu Q; Unger TL; Rha J; Johnson RS; Simon MC; Keith B; Haase VH. 2007. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 117(4):1068-77. PubMed: 17404621 MGI: J:121253
Rankin EB; Higgins DF; Walisser JA; Johnson RS; Bradfield CA; Haase VH. 2005. Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice. Mol Cell Biol 25(8):3163-72. PubMed: 15798202 MGI: J:97652
Rankin EB; Rha J; Selak MA; Unger TL; Keith B; Liu Q; Haase VH. 2009. Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. Mol Cell Biol 29(16):4527-38. PubMed: 19528226 MGI: J:151523
Rankin EB; Tomaszewski JE; Haase VH. 2006. Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor. Cancer Res 66(5):2576-83. PubMed: 16510575 MGI: J:106705
Rankin EB; Wu C; Khatri R; Wilson TL; Andersen R; Araldi E; Rankin AL; Yuan J; Kuo CJ; Schipani E; Giaccia AJ. 2012. The HIF signaling pathway in osteoblasts directly modulates erythropoiesis through the production of EPO. Cell 149(1):63-74. PubMed: 22464323 MGI: J:186085
Regan Anderson TM; Peacock DL; Daniel AR; Hubbard GK; Lofgren KA; Girard BJ; Schorg A; Hoogewijs D; Wenger RH; Seagroves TN; Lange CA. 2013. Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression. Cancer Res 73(18):5810-20. PubMed: 23928995 MGI: J:204358
Rempe D; Vangeison G; Hamilton J; Li Y; Jepson M; Federoff HJ. 2006. Synapsin I Cre transgene expression in male mice produces germline recombination in progeny. Genesis 44(1):44-9. PubMed: 16419044 MGI: J:105271
Riddle RC; Leslie JM; Gross TS; Clemens TL. 2011. Hypoxia-inducible Factor-1alpha Protein Negatively Regulates Load-induced Bone Formation. J Biol Chem 286(52):44449-56. PubMed: 22081627 MGI: J:178824
Ritter MR; Banin E; Moreno SK; Aguilar E; Dorrell MI; Friedlander M. 2006. Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. J Clin Invest 116(12):3266-76. PubMed: 17111048 MGI: J:117348
Rodriguez-Prados JC; Traves PG; Cuenca J; Rico D; Aragones J; Martin-Sanz P; Cascante M; Bosca L. 2010. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol 185(1):605-14. PubMed: 20498354 MGI: J:161403
Saini Y; Greenwood KK; Merrill C; Kim KY; Patial S; Parameswaran N; Harkema JR; LaPres JJ. 2010. Acute cobalt-induced lung injury and the role of hypoxia-inducible factor 1alpha in modulating inflammation. Toxicol Sci 116(2):673-81. PubMed: 20511350 MGI: J:162927
Saini Y; Harkema JR; LaPres JJ. 2008. HIF1alpha is essential for normal intrauterine differentiation of alveolar epithelium and surfactant production in the newborn lung of mice. J Biol Chem 283(48):33650-7. PubMed: 18801745 MGI: J:143384
Saini Y; Kim KY; Lewandowski R; Bramble LA; Harkema JR; Lapres JJ. 2010. Role of hypoxia-inducible factor 1{alpha} in modulating cobalt-induced lung inflammation. Am J Physiol Lung Cell Mol Physiol 298(2):L139-47. PubMed: 19915160 MGI: J:157680
Sarkar K; Cai Z; Gupta R; Parajuli N; Fox-Talbot K; Darshan MS; Gonzalez FJ; Semenza GL. 2012. Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning. Proc Natl Acad Sci U S A 109(26):10504-9. PubMed: 22699503 MGI: J:185580
Sarkar K; Rey S; Zhang X; Sebastian R; Marti GP; Fox-Talbot K; Cardona AV; Du J; Tan YS; Liu L; Lay F; Gonzalez FJ; Harmon JW; Semenza GL. 2012. Tie2-dependent knockout of HIF-1 impairs burn wound vascularization and homing of bone marrow-derived angiogenic cells. Cardiovasc Res 93(1):162-9. PubMed: 22028336 MGI: J:194712
Scheerer N; Dehne N; Stockmann C; Swoboda S; Baba HA; Neugebauer A; Johnson RS; Fandrey J. 2013. Myeloid hypoxia-inducible factor-1alpha is essential for skeletal muscle regeneration in mice. J Immunol 191(1):407-14. PubMed: 23729446 MGI: J:205360
Schipani E; Ryan HE; Didrickson S; Kobayashi T; Knight M; Johnson RS. 2001. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 15(21):2865-76. PubMed: 11691837 MGI: J:72709
Schmidt D; Textor B; Pein OT; Licht AH; Andrecht S; Sator-Schmitt M; Fusenig NE; Angel P; Schorpp-Kistner M. 2007. Critical role for NF-kappaB-induced JunB in VEGF regulation and tumor angiogenesis. EMBO J 26(3):710-9. PubMed: 17255940 MGI: J:119917
Schonenberger D; Harlander S; Rajski M; Jacobs RA; Lundby AK; Adlesic M; Hejhal T; Wild PJ; Lundby C; Frew IJ. 2016. Formation of Renal Cysts and Tumors in Vhl/Trp53-Deficient Mice Requires HIF1alpha and HIF2alpha. Cancer Res 76(7):2025-36. PubMed: 26759234 MGI: J:231634
Schwartz GJ; Gao X; Tsuruoka S; Purkerson JM; Peng H; D'Agati V; Picard N; Eladari D; Al-Awqati Q. 2015. SDF1 induction by acidosis from principal cells regulates intercalated cell subtype distribution. J Clin Invest 125(12):4365-74. PubMed: 26517693 MGI: J:229402
Scott A; Powner MB; Gandhi P; Clarkin C; Gutmann DH; Johnson RS; Ferrara N; Fruttiger M. 2010. Astrocyte-derived vascular endothelial growth factor stabilizes vessels in the developing retinal vasculature. PLoS One 5(7):e11863. PubMed: 20686684 MGI: J:163069
Seagroves TN; Hadsell D; McManaman J; Palmer C; Liao D; McNulty W; Welm B; Wagner KU; Neville M; Johnson RS. 2003. HIF1alpha is a critical regulator of secretory differentiation and activation, but not vascular expansion, in the mouse mammary gland. Development 130(8):1713-24. PubMed: 12620994 MGI: J:82618
Seagroves TN; Peacock DL; Liao D; Schwab LP; Krueger R; Handorf CR; Haase VH; Johnson RS. 2010. VHL deletion impairs mammary alveologenesis but is not sufficient for mammary tumorigenesis. Am J Pathol 176(5):2269-82. PubMed: 20382704 MGI: J:160375
Segura I; Lange C; Knevels E; Moskalyuk A; Pulizzi R; Eelen G; Chaze T; Tudor C; Boulegue C; Holt M; Daelemans D; Matondo M; Ghesquiere B; Giugliano M; Ruiz de Almodovar C; Dewerchin M; Carmeliet P. 2016. The Oxygen Sensor PHD2 Controls Dendritic Spines and Synapses via Modification of Filamin A. Cell Rep 14(11):2653-67. PubMed: 26972007 MGI: J:234716
Semba H; Takeda N; Isagawa T; Sugiura Y; Honda K; Wake M; Miyazawa H; Yamaguchi Y; Miura M; Jenkins DM; Choi H; Kim JW; Asagiri M; Cowburn AS; Abe H; Soma K; Koyama K; Katoh M; Sayama K; Goda N; Johnson RS; Manabe I; Nagai R; Komuro I. 2016. HIF-1alpha-PDK1 axis-induced active glycolysis plays an essential role in macrophage migratory capacity. Nat Commun 7:11635. PubMed: 27189088 MGI: J:239927
Shi LZ; Wang R; Huang G; Vogel P; Neale G; Green DR; Chi H. 2011. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 208(7):1367-76. PubMed: 21708926 MGI: J:176809
Shoham AB; Malkinson G; Krief S; Shwartz Y; Ely Y; Ferrara N; Yaniv K; Zelzer E. 2012. S1P1 inhibits sprouting angiogenesis during vascular development. Development 139(20):3859-69. PubMed: 22951644 MGI: J:187683
Shomento SH; Wan C; Cao X; Faugere MC; Bouxsein ML; Clemens TL; Riddle RC. 2010. Hypoxia-inducible factors 1alpha and 2alpha exert both distinct and overlapping functions in long bone development. J Cell Biochem 109(1):196-204. PubMed: 19899108 MGI: J:161255
Shui YB; Arbeit JM; Johnson RS; Beebe DC. 2008. HIF-1: an age-dependent regulator of lens cell proliferation. Invest Ophthalmol Vis Sci 49(11):4961-70. PubMed: 18586877 MGI: J:141905
Singh RP; Franke K; Kalucka J; Mamlouk S; Muschter A; Gembarska A; Grinenko T; Willam C; Naumann R; Anastassiadis K; Stewart AF; Bornstein S; Chavakis T; Breier G; Waskow C; Wielockx B. 2013. HIF prolyl hydroxylase 2 (PHD2) is a critical regulator of hematopoietic stem cell maintenance during steady-state and stress. Blood 121(26):5158-66. PubMed: 23667053 MGI: J:200956
Skuli N; Liu L; Runge A; Wang T; Yuan L; Patel S; Iruela-Arispe L; Simon MC; Keith B. 2009. Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis. Blood 114(2):469-77. PubMed: 19439736 MGI: J:150753
Skuli N; Majmundar AJ; Krock BL; Mesquita RC; Mathew LK; Quinn ZL; Runge A; Liu L; Kim MN; Liang J; Schenkel S; Yodh AG; Keith B; Simon MC. 2012. Endothelial HIF-2alpha regulates murine pathological angiogenesis and revascularization processes. J Clin Invest 122(4):1427-43. PubMed: 22426208 MGI: J:184551
Smeyne M; Sladen P; Jiao Y; Dragatsis I; Smeyne RJ. 2015. HIF1alpha is necessary for exercise-induced neuroprotection while HIF2alpha is needed for dopaminergic neuron survival in the substantia nigra pars compacta. Neuroscience 295:23-38. PubMed: 25796140 MGI: J:222648
Stegen S; Deprez S; Eelen G; Torrekens S; Van Looveren R; Goveia J; Ghesquiere B; Carmeliet P; Carmeliet G. 2016. Adequate hypoxia inducible factor 1alpha signaling is indispensable for bone regeneration. Bone 87:176-86. PubMed: 27058876 MGI: J:235528
Tajima T; Goda N; Fujiki N; Hishiki T; Nishiyama Y; Senoo-Matsuda N; Shimazu M; Soga T; Yoshimura Y; Johnson RS; Suematsu M. 2009. HIF-1alpha is necessary to support gluconeogenesis during liver regeneration. Biochem Biophys Res Commun 387(4):789-94. PubMed: 19643083 MGI: J:152724
Takubo K; Goda N; Yamada W; Iriuchishima H; Ikeda E; Kubota Y; Shima H; Johnson RS; Hirao A; Suematsu M; Suda T. 2010. Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell 7(3):391-402. PubMed: 20804974 MGI: J:164436
Takubo K; Nagamatsu G; Kobayashi CI; Nakamura-Ishizu A; Kobayashi H; Ikeda E; Goda N; Rahimi Y; Johnson RS; Soga T; Hirao A; Suematsu M; Suda T. 2013. Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell 12(1):49-61. PubMed: 23290136 MGI: J:194930
Tang N; Mack F; Haase VH; Simon MC; Johnson RS. 2006. pVHL function is essential for endothelial extracellular matrix deposition. Mol Cell Biol 26(7):2519-30. PubMed: 16537898 MGI: J:106926
Tang N; Wang L; Esko J; Giordano FJ; Huang Y; Gerber HP; Ferrara N; Johnson RS. 2004. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 6(5):485-95. PubMed: 15542432 MGI: J:94773
Thiel M; Caldwell CC; Kreth S; Kuboki S; Chen P; Smith P; Ohta A; Lentsch AB; Lukashev D; Sitkovsky MV. 2007. Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS One 2(9):e853. PubMed: 17786224 MGI: J:129383
Thiersch M; Lange C; Joly S; Heynen S; Le YZ; Samardzija M; Grimm C. 2009. Retinal neuroprotection by hypoxic preconditioning is independent of hypoxia-inducible factor-1 alpha expression in photoreceptors. Eur J Neurosci 29(12):2291-302. PubMed: 19508692 MGI: J:151531
Thom R; Rowe GC; Jang C; Safdar A; Arany Z. 2014. Hypoxic induction of vascular endothelial growth factor (VEGF) and angiogenesis in muscle by truncated peroxisome proliferator-activated receptor gamma coactivator (PGC)-1alpha. J Biol Chem 289(13):8810-7. PubMed: 24505137 MGI: J:212445
Thompson AA; Elks PM; Marriott HM; Eamsamarng S; Higgins KR; Lewis A; Williams L; Parmar S; Shaw G; McGrath EE; Formenti F; Van Eeden FJ; Kinnula VL; Pugh CW; Sabroe I; Dockrell DH; Chilvers ER; Robbins PA; Percy MJ; Simon MC; Johnson RS; Renshaw SA; Whyte MK; Walmsley SR. 2014. Hypoxia-inducible factor 2alpha regulates key neutrophil functions in humans, mice, and zebrafish. Blood 123(3):366-76. PubMed: 24196071 MGI: J:207679
Tomlinson RE; Silva MJ. 2015. HIF-1alpha regulates bone formation after osteogenic mechanical loading. Bone 73:98-104. PubMed: 25541207 MGI: J:220899
Urrutia AA; Afzal A; Nelson J; Davidoff O; Gross KW; Haase VH. 2016. Prolyl-4-hydroxylase 2 and 3 coregulate murine erythropoietin in brain pericytes. Blood 128(21):2550-2560. PubMed: 27683416 MGI: J:237355
Usui Y; Westenskow PD; Kurihara T; Aguilar E; Sakimoto S; Paris LP; Wittgrove C; Feitelberg D; Friedlander MS; Moreno SK; Dorrell MI; Friedlander M. 2015. Neurovascular crosstalk between interneurons and capillaries is required for vision. J Clin Invest 125(6):2335-46. PubMed: 25915585 MGI: J:222971
Velasco-Hernandez T; Hyrenius-Wittsten A; Rehn M; Bryder D; Cammenga J. 2014. HIF-1alpha can act as a tumor suppressor gene in murine acute myeloid leukemia. Blood 124(24):3597-607. PubMed: 25267197 MGI: J:220797
Velasco-Hernandez T; Tornero D; Cammenga J. 2015. Loss of HIF-1alpha accelerates murine FLT-3(ITD)-induced myeloproliferative neoplasia. Leukemia 29(12):2366-74. PubMed: 26104662 MGI: J:227310
Vukovic M; Guitart AV; Sepulveda C; Villacreces A; O'Duibhir E; Panagopoulou TI; Ivens A; Menendez-Gonzalez J; Iglesias JM; Allen L; Glykofrydis F; Subramani C; Armesilla-Diaz A; Post AE; Schaak K; Gezer D; So CW; Holyoake TL; Wood A; O'Carroll D; Ratcliffe PJ; Kranc KR. 2015. Hif-1alpha and Hif-2alpha synergize to suppress AML development but are dispensable for disease maintenance. J Exp Med 212(13):2223-34. PubMed: 26642852 MGI: J:229015
Vukovic M; Sepulveda C; Subramani C; Guitart AV; Mohr J; Allen L; Panagopoulou TI; Paris J; Lawson H; Villacreces A; Armesilla-Diaz A; Gezer D; Holyoake TL; Ratcliffe PJ; Kranc KR. 2016. Adult hematopoietic stem cells lacking Hif-1alpha self-renew normally. Blood 127(23):2841-6. PubMed: 27060169 MGI: J:234801
Walmsley SR; Print C; Farahi N; Peyssonnaux C; Johnson RS; Cramer T; Sobolewski A; Condliffe AM; Cowburn AS; Johnson N; Chilvers ER. 2005. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J Exp Med 201(1):105-15. PubMed: 15630139 MGI: J:95245
Walter KM; Schonenberger MJ; Trotzmuller M; Horn M; Elsasser HP; Moser AB; Lucas MS; Schwarz T; Gerber PA; Faust PL; Moch H; Kofeler HC; Krek W; Kovacs WJ. 2014. Hif-2alpha promotes degradation of mammalian peroxisomes by selective autophagy. Cell Metab 20(5):882-97. PubMed: 25440060 MGI: J:218787
Wan C; Gilbert SR; Wang Y; Cao X; Shen X; Ramaswamy G; Jacobsen KA; Alaql ZS; Eberhardt AW; Gerstenfeld LC; Einhorn TA; Deng L; Clemens TL. 2008. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci U S A 105(2):686-91. PubMed: 18184809 MGI: J:131088
Wang H; Flach H; Onizawa M; Wei L; McManus MT; Weiss A. 2014. Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210. Nat Immunol 15(4):393-401. PubMed: 24608041 MGI: J:210247
Wang R; Dillon CP; Shi LZ; Milasta S; Carter R; Finkelstein D; McCormick LL; Fitzgerald P; Chi H; Munger J; Green DR. 2011. The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation. Immunity 35(6):871-82. PubMed: 22195744 MGI: J:179281
Wang Y; Wan C; Deng L; Liu X; Cao X; Gilbert SR; Bouxsein ML; Faugere MC; Guldberg RE; Gerstenfeld LC; Haase VH; Johnson RS; Schipani E; Clemens TL. 2007. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 117(6):1616-26. PubMed: 17549257 MGI: J:122021
Wei H; Bedja D; Koitabashi N; Xing D; Chen J; Fox-Talbot K; Rouf R; Chen S; Steenbergen C; Harmon JW; Dietz HC; Gabrielson KL; Kass DA; Semenza GL. 2012. Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-beta signaling. Proc Natl Acad Sci U S A 109(14):E841-50. PubMed: 22403061 MGI: J:182677
Weidemann A; Kerdiles YM; Knaup KX; Rafie CA; Boutin AT; Stockmann C; Takeda N; Scadeng M; Shih AY; Haase VH; Simon MC; Kleinfeld D; Johnson RS. 2009. The glial cell response is an essential component of hypoxia-induced erythropoiesis in mice. J Clin Invest 119(11):3373-83. PubMed: 19809162 MGI: J:154613
Weidemann A; Krohne TU; Aguilar E; Kurihara T; Takeda N; Dorrell MI; Simon MC; Haase VH; Friedlander M; Johnson RS. 2010. Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina. Glia 58(10):1177-85. PubMed: 20544853 MGI: J:168049
Weigert A; Weichand B; Sekar D; Sha W; Hahn C; Mora J; Ley S; Essler S; Dehne N; Brune B. 2012. HIF-1alpha is a negative regulator of plasmacytoid DC development in vitro and in vivo. Blood 120(15):3001-6. PubMed: 22936665 MGI: J:192921
Welford SM; Bedogni B; Gradin K; Poellinger L; Broome Powell M; Giaccia AJ. 2006. HIF1alpha delays premature senescence through the activation of MIF. Genes Dev 20(24):3366-71. PubMed: 17142669 MGI: J:116762
Wong MS; Leisegang MS; Kruse C; Vogel J; Schurmann C; Dehne N; Weigert A; Herrmann E; Brune B; Shah AM; Steinhilber D; Offermanns S; Carmeliet G; Badenhoop K; Schroder K; Brandes RP. 2014. Vitamin D promotes vascular regeneration. Circulation 130(12):976-86. PubMed: 25015343 MGI: J:227457
Wong WJ; Richardson T; Seykora JT; Cotsarelis G; Simon MC. 2015. Hypoxia-inducible factors regulate filaggrin expression and epidermal barrier function. J Invest Dermatol 135(2):454-61. PubMed: 24999590 MGI: J:217942
Wu C; Rankin EB; Castellini L; Fernandez-Alcudia J; LaGory EL; Andersen R; Rhodes SD; Wilson TL; Mohammad KS; Castillo AB; Guise TA; Schipani E; Giaccia AJ. 2015. Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. Genes Dev 29(8):817-31. PubMed: 25846796 MGI: J:221580
Xie L; Johnson RS; Freeman RS. 2005. Inhibition of NGF deprivation-induced death by low oxygen involves suppression of BIMEL and activation of HIF-1. J Cell Biol 168(6):911-20. PubMed: 15767462 MGI: J:98249
Yuen TJ; Silbereis JC; Griveau A; Chang SM; Daneman R; Fancy SP; Zahed H; Maltepe E; Rowitch DH. 2014. Oligodendrocyte-encoded HIF function couples postnatal myelination and white matter angiogenesis. Cell 158(2):383-96. PubMed: 25018103 MGI: J:214629
Zehetner J; Danzer C; Collins S; Eckhardt K; Gerber PA; Ballschmieter P; Galvanovskis J; Shimomura K; Ashcroft FM; Thorens B; Rorsman P; Krek W. 2008. pVHL is a regulator of glucose metabolism and insulin secretion in pancreatic {beta} cells. Genes Dev 22(22):3135-46. PubMed: 19056893 MGI: J:142036
Zelzer E; Mamluk R; Ferrara N; Johnson RS; Schipani E; Olsen BR. 2004. VEGFA is necessary for chondrocyte survival during bone development. Development 131(9):2161-71. PubMed: 15073147 MGI: J:89363
Zhang H; Li H; Xi HS; Li S. 2012. HIF1alpha is required for survival maintenance of chronic myeloid leukemia stem cells. Blood 119(11):2595-607. PubMed: 22275380 MGI: J:182536
Zhang S; Han CH; Chen XS; Zhang M; Xu LM; Zhang JJ; Xia Q. 2012. Transient ureteral obstruction prevents against kidney ischemia/reperfusion injury via hypoxia-inducible factor (HIF)-2alpha activation. PLoS One 7(1):e29876. PubMed: 22295069 MGI: J:222349
Zhou J; Dehne N; Brune B. 2009. Nitric oxide causes macrophage migration via the HIF-1-stimulated small GTPases Cdc42 and Rac1. Free Radic Biol Med 47(6):741-9. PubMed: 19523512 MGI: J:152571
Zhu Y; Zhang L; Gidday JM. 2013. Role of hypoxia-inducible factor-1alpha in preconditioning-induced protection of retinal ganglion cells in glaucoma. Mol Vis 19:2360-72. PubMed: 24319330 MGI: J:211869

Also Known As: HIF1αflox

Donating Investigator

Genetic overview

Research Applications

Base Price

Detailed Description

Development

Control Suggestions

Additional Information

Selected References

Hif1atm3Rsjo

Allele Symbol: Hif1atm3Rsjo

Disease Terms

Research Areas By Genotype

This mouse can be used to support research in many areas including:

Mammalian Phenotype Terms by Genotype

Genotype: Hif1atm3Rsjo/Hif1atm3Rsjoinvolves: 129S1/Sv * 129X1/SvJ

homeostasis/metabolism phenotype

cellular phenotype

liver/biliary system phenotype

Genotype: Hif1atm3Rsjo/Hif1atm3Rsjo Lyz2tm1(cre)Ifo/Lyz2+involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ

immune system phenotype

homeostasis/metabolism phenotype

skeleton phenotype

cellular phenotype

hematopoietic system phenotype

Genotype: Hif1atm3Rsjo/Hif1atm3Rsjo Lyz2tm1(cre)Ifo/Lyz2+involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6

mortality/aging

immune system phenotype

homeostasis/metabolism phenotype

cardiovascular system phenotype

Genotype: Hif1atm3Rsjo/Hif1atm3Rsjo Vhltm1Jae/Vhltm1Jae Tg(Alb-cre)21Mgn/0involves: 129 * BALB/c * C57BL/6 * DBA

liver/biliary system phenotype

cardiovascular system phenotype

muscle phenotype

Genotype: Hif1atm3Rsjo/Hif1atm3Rsjo Tg(Ckmm-cre)5Khn/?involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N

muscle phenotype

homeostasis/metabolism phenotype

nervous system phenotype

Genotype: Hif1atm3Rsjo/Hif1atm3Rsjo Tg(Itgax-cre)1-1Reiz/0involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA

immune system phenotype

cellular phenotype

hematopoietic system phenotype

Genotype: Hif1atm3Rsjo/Hif1atm3Rsjo Tg(MMTV-cre)1Mam/0involves: 129S1/Sv * 129X1/SvJ * CD-1 * FVB

endocrine/exocrine gland phenotype

cardiovascular system phenotype

integument phenotype

Genotype: Hif1atm3Rsjo/Hif1atm3Rsjo Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6

mortality/aging

respiratory system phenotype

homeostasis/metabolism phenotype

Genotype: Hif1atm3Rsjo/Hif1atm3Rsjo Tg(Tek-cre)1Ywa/0involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL

cardiovascular system phenotype

neoplasm

homeostasis/metabolism phenotype

cellular phenotype

Genotype: Hif1atm3Rsjo/Hif1atm3Rsjo Tg(UBC-cre/ERT2)1Ejb/0involves: 129S1/Sv * 129X1/SvJ

immune system phenotype

References

Additional - Hif1atm3Rsjo related

Genotyping Protocols

Dietary Information

Breeding Considerations

Mating System

Animal Health Reports

Live Mouse

Cryorecovery - Pricing

Progeny testing is not required

Payment Terms and Conditions

The Jackson Laboratory's Genotype Promise

Terms of Use

Licensing Information

JAX® Mice, Products & Services Conditions of Use

No Warranty

Credit for PRODUCTS or SERVICES

Animal Care and Use for SERVICES

No Liability

Also Known As: HIF1α^flox

Hif1a^tm3Rsjo

Allele Symbol: Hif1a^tm3Rsjo

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo
involves: 129S1/Sv * 129X1/SvJ

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Lyz2^tm1(cre)Ifo/Lyz2⁺
involves: 129P2/OlaHsd 129S1/Sv 129X1/SvJ

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Lyz2^tm1(cre)Ifo/Lyz2⁺
involves: 129P2/OlaHsd 129S1/Sv 129X1/SvJ * C57BL/6

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Vhl^tm1Jae/Vhl^tm1Jae Tg(Alb-cre)21Mgn/0
involves: 129 * BALB/c * C57BL/6 * DBA

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(Ckmm-cre)5Khn/?
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(Itgax-cre)1-1Reiz/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(MMTV-cre)1Mam/0
involves: 129S1/Sv * 129X1/SvJ * CD-1 * FVB

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0
involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(Tek-cre)1Ywa/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL

Genotype: Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(UBC-cre/ERT2)1Ejb/0
involves: 129S1/Sv * 129X1/SvJ

Additional - Hif1a^tm3Rsjo related